| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0N0Q0 | Chemokine (C-C motif) receptor 7; cDNA FLJ45911 fis, clone PEBLM2005615, highly similar to C-C chemokine receptor type 7; | CCR7; | NP_001829.1; | 378 | human |
| M0QZR2 | Zinc finger protein 615; | ZNF615; | NULL | 98 | human |
| H0Y310 | Zinc finger protein 23; | ZNF23; | NULL | 83 | human |
| A8K122 | KIAA1946, isoform CRA_b; cDNA FLJ77486; | KIAA1946; | NULL | 827 | human |
| L0EQS1 | Cellular tumor antigen p53; Fragment; | TP53; | NULL | 99 | human |
| L7SJJ7 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| Q2KJU6 | TNF receptor-associated factor 4; TRAF4 variant 3; | TRAF4; | NULL | 144 | human |
| B7Z6T3 | Transmembrane protein 161B; cDNA FLJ59764; | TMEM161B; | NP_001275936.1;NP_001275937.1;NP_699185.1; | 476 | human |
| Q7Z2J0 | L1 cell adhesion molecule; Fragment; | L1CAM; | NULL | 83 | human |
| Q4GTI4 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | NADH5; ND5; | NULL | 603 | human |
| H0YEU4 | Histone-lysine N-methyltransferase 2A; Fragment; | KMT2A; | NULL | 87 | human |
| B4E3T5 | Caspase-10 subunit p23/17; cDNA FLJ61090, highly similar to Caspase-10 (EC 3.4.22.-); | CASP10; | NULL | 118 | human |
| A0A023QWK0 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
| Q5J1K9 | Ecto-ADP-ribosyltransferase 3; Mono-ADP-ribosyltransferase 3 variant Ia; Fragment; | ART3; | NULL | 117 | human |
| B0JEG1 | RhD protein; Rhesus blood group D antigen; | RHD; | NULL | 417 | human |
| L7REZ6 | TRIM5; Fragment; | TRIM5; | NULL | 62 | human |
| D3DW67 | HCG40815, isoform CRA_b; | NULL | NULL | 257 | human |
| M4Q9M0 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; | ND1; | NULL | 318 | human |
| E5E1A6 | Cytochrome c oxidase subunit 2; | COX2; | NULL | 227 | human |
| B4DVN3 | Macrophage erythroblast attacher; cDNA FLJ54556, highly similar to Homo sapiens macrophage erythroblast attacher (MAEA), transcript variant 1, mRNA; | MAEA; | NP_001284361.1; | 395 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |